CannTrust Holdings Inc.

The cannabis industry has manufacturing operations in China. The coronavirus outbreak revealed some of the pitfalls in the marijuana supply chain. 

Mississippi has been trying to put a legalization initiative on the November ballot. However, lawmakers’ new strategy makes legalization difficult.

Cannabis demand is rising, but there seems to be a gap between cannabis demand and supply in Canada. Let’s take a closer look at the imbalance.

Weakness in cannabis stocks continued today, the fourth day of decline. The US equity market fell today due to the growing tension between the US and Iran.

Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.

CannTrust (CTST) stock has experienced a surprising turn of events in January. The stock has gained good upward momentum.

On December 26, a Santa Claus rally seems to be in full swing. This effect pushed the S&P 500 (SPX) and Nasdaq Composite Index (COMP) to record highs.

Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.

Beleaguered cannabis company CannTrust (CTST)(TRST) received a notice from the NYSE that the company is no longer in compliance with its listing rules.

Today, the cannabis sector was trading in the red, with multiple ETFs losing ground. Here, we’ll have a look at cannabis stocks that are in the news today.

Cannabis is slowly picking up steam again, with more states are pushing to legalize. However, it appears the challenges never end in the marijuana sector.

The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.

Marijuana legalization in the US remains in limbo. Most Democrats have endorsed marijuana legalization. However, Republicans have yet to embrace it fully.

In October, Canada completed the second phase of recreational cannabis legalization. This was expected to help drive sales. But that hasn’t been the case.

The Canadian cannabis company CannTrust (CTST) announced that the Toronto Stock Exchange is reviewing the company’s listing.

Canopy Growth (WEED)(CGC) got a rare upgrade to “buy” from Bank of America today. Find out what drove the change—and what’s next.

Despite Canada’s legalization of cannabis a year ago, a StatCan survey found that 42% of Canadians have obtained their cannabis from illegal sources.

Last week, HEXO Corporation (HEXO) issued a press release that provided more information about its Niagara facility license.

CannTrust (CTST) stock is gradually recovering after it hit an all-time low of $0.82 last month. However, the worst for the company isn’t over yet.

In the fourth-quarter earnings call, HEXO discussed how it thinks that legal cannabis won’t solve the problem with the illegal market in Canada.

Cannabis is an evolving sector. Recently, Warren Buffett entered the space following Kraft Heinz’s (KHC) newest investment in Flowhub.

At 12:51 PM ET, the S&P 500 Index and the Dow Jones Industrial Average were up 0.5% and 0.7%, respectively. The cannabis sector was also up today.

When May 1, 2020, rolls around, you’ll won’t be able to smoke hemp in North Carolina legally. Just yesterday, the North Carolina House passed the North Carolina Farm Act with revisions to restrict smokable hemp. Why was it banned? The smokable hemp ban was widely supported by law enforcement agencies. Law enforcement officers might find […]

The cannabis industry is fighting against the ongoing US-China trade war and recessionary worries, which have hurt valuations across the global market.

Today CannTrust Holdings is trading at $1.30 on the NYSE, 25.60% higher than its last closing price. It’s risen even faster on the Toronto Stock Exchange.

With a boost from Aphria’s (APHA) impressive first-quarter earnings, cannabis stocks and ETFs were trading higher today. Let’s take a closer look.

The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.

By the end of September, HEXO was one of the few cannabis companies to have delivered positive returns in 2019. However, this month has been tough.

Scandals have engulfed the sector many times, especially for CannTrust, Curaleaf, and Hexo. Could Tilray be next on the cannabis scandal radar?

The cannabis sector continued its downward movement in the week that ended on October 10, with ETFs and prominent cannabis players falling.

Cannabis players are having a hard time this year. Regulatory concerns and weaker earnings due to the vaping-related crisis took a toll on the sector.

Today, President Trump announced that a US-China trade deal could happen earlier than expected. Equities were up, but cannabis stocks were mixed.

While Aphria’s consensus target price fell after its earnings, most analysts remain bullish on the stock. The overall “strong-buy” rating didn’t change.

CannTrust (CTST) (TRST) was one of the worst performers in the cannabis sector last week. The stock lost almost 19.6% in one week alone.

The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.

Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.

Democratic presidential candidate Beto O’Rourke is known for voicing his opinion on federal marijuana legalization. He supports marijuana legalization.

Today, the US cannabis markets were trading a little higher than we have seen in the recent past. The Federal Reserve cut interest rates by 25 points.

Oppenheimer analyst Rupesh Parikh initiated coverage on Canopy Growth stock. The analyst gave a “perform” rating with no target price.

The SAFE Banking Act is gaining traction again, as House Majority Leader Steny Hoyer is expected to bring the banking bill to the House floor for a vote.

CannTrust reported that its license under the Cannabis Act was suspended. The company won’t be able to produce cannabis. Will CannTrust fall below $1?.

Today at 2:10 PM ET, the S&P 500 Index fell 0.3% as investors watched rising oil prices. The cannabis sector also fell today, as its ETFs traded in the red.

With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.

Cannabis legalization is gaining traction not only in the US but also globally. The third presidential Democratic debate was held on September 12.

On Tuesday, Eight Capital removed its target price for CannTrust Holdings due to uncertainty about the risks involved in the company’s future operations.

After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150.

On September 6, CannTrust Holdings (TRST) (CTST) was trading at 2.33 Canadian dollars. This marked a discount of 85% from its 52-week high.

Cannabis ETFs the ETFMG Alternative Harvest ETF and the Horizons Marijuana Life Sciences Index ETF were up 2.0% and 1.7%, respectively, at 1:20 PM today.

News that the US and China plan to revive trade talks in October boosted the US stock market. Most of the cannabis players traded in the green today.

Canada’s next wave of cannabis legalization allows edibles, beverages, extracts, and topicals on October 17. The products could hit the stores in December.

HEXO stock has suffered since it reported lower-than-expected third-quarter results in June. The stock has fallen 31.8% since its earnings on June 12.

CannTrust (CTST) was hit with selling pressure this morning as its stock declined almost 5%. However, the overall cannabis sector seems to be positive

In the wake of its regulatory scandals, the cannabis sector lagged the equity market in August. YTD, MJ and HMMJ have fallen 3.7% and 1.5%, respectively.

Cronos Group (CRON) reported its Q2 results last month. Despite better-than-expected sales, its Q2 losses widened and its stock has fallen 23% since then.

Cannabis legalization is a hot topic. With the sudden boom in the cannabis industry, legalization at the national level is vital.

According to the CDC, about 400,000 people died from opioid overdoses from 1999 to 2017. The number includes deaths from prescription and illegal opioids.

In 2012, Washington was the second state to legalize recreational marijuana. Now, the state plans to revamp its marijuana laws.

Aurora Cannabis stock got a boost at the beginning of the month. The company updated its guidance for the fourth quarter.

Analysts expect OrganiGram to report revenues of 96.9 million Canadian dollars in fiscal 2019 and 206.5 million Canadian dollars in 2020.

Canopy Growth (CGC) (WEED) received optimistic views from analysts on Monday. Seaport Global Securities upgraded the stock to “buy” from “neutral.”

The trade war might impact the marijuana industry. The US-China trade war has been an ongoing issue. President Trump imposed tariffs on China in May.

Coverage on Cresco Labs has increased from seven analysts in July to nine in August. Six analysts favor a “strong buy,” and three recommend a “buy.”

MedMen (MMNFF) (MMEN) closed 1.9% higher on Thursday. The company launched a 2020 ballot initiative called “Make it Legal Florida.”

HEXO reported its third-quarter earnings on June 12. The company reported revenues of $13.0 million, which fell short of analysts’ estimate.

Marijuana reform is central to Beto O’Rourke’s 2020 presidential campaign—how could his agenda that affect the cannabis industry?

Marijuana is a hot topic right now! From presidential candidates to the wealthiest Americans, everyone is talking about the sector.

On Tuesday, Jim Cramer stated that Cronos Group and Aphria passed Canopy Growth. Canopy Growth has lost 15.3% of its stock value since its Q1 earnings.

Cresco Labs (CRLBF) is all set to report its second-quarter results after the market closes today. Cresco stock tanked 6.9% yesterday.

In May, NYC mayor Bill de Blasio announced he was running for the 2020 Democratic presidential nomination. Initially, he was against legalizing cannabis.

The cannabis industry has been in the spotlight this year, and now the FBI is investigating allegations of corruption in this nascent industry.

MedMen (MMNFF) closed almost 6% higher on Monday. The company announced the launch of its new California-wide delivery service for cannabis.

Bernie Sanders tweeted his support for legalizing marijuana nationally and expunging past marijuana convictions. How could this impact cannabis stocks?

Today, Canopy Growth (WEED) (CGC) stock saw its lowest point in 2019. The stock opened at $28.3 but fell to $26.5 in the afternoon.

Cannabis companies face regulatory challenges. Recently, CannTrust (CTST) didn’t comply with Health Canada’s regulations.

As of August 13, HEXO (HEXO) was trading at 6.51 Canadian dollars—a fall of 30.9% since its third-quarter earnings on June 12.

Cresco Labs (CRLBF) is set to report its Q2 earnings on August 21 after the market closes. The company’s stock fell 5.3% yesterday.

Canopy Growth’s weak results weighed on the entire cannabis sector. Most of the cannabis stocks were in the red on Thursday.

Aurora Cannabis (ACB) announced that it’s increasing its secured credit facility to 360 million Canadian dollars from $200 million Canadian dollars.

CNN reported that heavyweight champion Mike Tyson said they smoke 10 tons of weed, worth about $40,000, at his California marijuana ranch per month.

Canopy Growth (CGC) (WEED) is scheduled to announce its results for the first quarter of fiscal 2020 after the market closes on Wednesday.

It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.

As of Monday, CannTrust was trading at 3.04 Canadian dollars. The company has lost 53.6% of its stock value since the beginning of July.

Tilray (TLRY) is scheduled to release its second-quarter results today after the market closes. Lately, Tilray stock has been off the radar.

Cresco Labs is due to report its Q2 earnings on August 21 after the market closes. A week ahead, it received regulatory approval for a New York deal.

Early on Monday, CannTrust (CTST) fell almost 26.8%. The development came after Health Canada found more areas that didn’t comply with regulations.

So far, Innovative Industrial Properties (IIPR) stock has been impressive in 2019. The stock has gained almost 126% year-to-date.

CannTrust (CTST), a popular name in the cannabis sector, has been falling on Friday. The stock has fallen 6.2% as of 10:51 AM ET.

Canopy Growth (CGC) rose 1.5% today while Cronos Group (CRON) fell 3.8%. CNBC host Jim Cramer favors both stocks amid several weed industry scandals.

Joe Biden wants to change the criminal justice system because he “believes no one should be in jail because of cannabis use.”

Aphria (APHA) had stellar Q4 earnings results. Its operating metrics significantly improved, turning its bottom line positive.

The Ontario Securities Commission opened an investigation into CannTrust’s alleged activities related to violation of Health Canada’s regulations.

On Thursday, Aphria (APHA) is scheduled to release its fourth-quarter and fiscal 2019 earnings results after the market closes.

Scotts Miracle-Gro (SMG) reported its earnings this morning. Now SMG is surging alongside CannTrust and Emerald Health stocks. Here’s why.

SMG stock became hot last year with other core cannabis stocks like Canopy Growth (WEED) (CGC), Aurora Cannabis (ACB), and Tilray (TLRY).

CannTrust and HEXO have tried to calm investors after facing controversy. However, CTST and HEXO stock movement suggests investors aren’t convinced.

Aphria (APHA) is set to announce its fiscal 2019 fourth-quarter results on Thursday. Analysts expect the company’s sales to grow 47% sequentially.

CRON stock has lost almost 11% in July. With only two more trading days left in the month, the stock will likely end in the negative territory.

HEXO (HEXO) stock lost nearly 18% in the week ending July 26. There weren’t any catalysts that showed weakness in the stock.

On July 25, CannTrust stock jumped almost 15% after the market closed driven by the company’s announcement of leadership changes.

So far, July has been rough for Aurora Cannabis (ACB). The stock has been trending lower ever since the beginning of the month. As of Thursday, the stock has fallen about 17%. However, the stock has delivered a positive return this year. Aurora Cannabis has delivered a positive return of 30% YTD (year-to-date). When we […]